This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Advanced Adenocarcinoma of Pancreas
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.

Provided treatments

  • Drug: IV CP-4126
Tris trial is registered with FDA with number: NCT00913198. The sponsor of the trial is Clavis Pharma and it is looking for 21 volunteers for the current phase.
Official trial title:
A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.